Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 183

1.

The role of middle managers in tobacco control after a national smoke-free hospital campus ban.

Martínez C, Ballbè M, Vilardell M, Fu M, Fernández E.

BMC Health Serv Res. 2016 Sep 23;16(1):517.

2.

[Descriptive Study of sickness absence in the health care sector of Catalonia (2009-2012)].

Vilardell M, Esteve Pardo M, Carreras Valls R, Olivé Cristany V, Bretau Viñas F, Subirats Cid P, Sánchez Flores E, Villegas Rodríguez S, Guixeras Campos A, Torrecillas Mota S, Barroso Reinon S, Serra Pujadas C, Santiñà Vila M.

Arch Prev Riesgos Labor. 2016 Jan-Mar;19(1):15-21. doi: 10.12961/aprl.2016.19.1.03. Spanish.

PMID:
27250623
3.

[Training doctors for the future: A review 10 years later].

Cardellach F, Vilardell M, Pujol R.

Med Clin (Barc). 2016 Oct 7;147(7):313-5. doi: 10.1016/j.medcli.2016.02.024. Epub 2016 Mar 28. Spanish. No abstract available.

PMID:
27033432
4.

Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective.

Herwig R, Gmuender H, Corvi R, Bloch KM, Brandenburg A, Castell J, Ceelen L, Chesne C, Doktorova TY, Jennen D, Jennings P, Limonciel A, Lock EA, McMorrow T, Phrakonkham P, Radford R, Slattery C, Stierum R, Vilardell M, Wittenberger T, Yildirimman R, Ryan M, Rogiers V, Kleinjans J.

Arch Toxicol. 2016 Sep;90(9):2215-29. doi: 10.1007/s00204-015-1617-3. Epub 2015 Nov 2.

PMID:
26525393
5.

Anti-SSA/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study.

Sánchez-Montalvá A, Fernández-Luque A, Simeón CP, Fonollosa-Plà V, Marín A, Guillén A, Vilardell M.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-177-82. Epub 2014 Nov 5.

PMID:
25372801
6.

WISCOD: a statistical web-enabled tool for the identification of significant protein coding regions.

Vilardell M, Parra G, Civit S.

Biomed Res Int. 2014;2014:282343. doi: 10.1155/2014/282343. Epub 2014 Sep 15.

7.

[Proportion of breast cancer in women aged 50 to 69 years from Girona, Spain, according to detection method].

Puig-Vives M, Osca-Gelis G, Camprubí-Font C, Vilardell ML, Izquierdo A, Marcos-Gragera R.

Med Clin (Barc). 2014 Oct 7;143(7):300-2. doi: 10.1016/j.medcli.2013.09.042. Epub 2013 Dec 28. Spanish.

PMID:
24378145
8.

Testing chemical carcinogenicity by using a transcriptomics HepaRG-based model?

Doktorova TY, Yildirimman R, Ceelen L, Vilardell M, Vanhaecke T, Vinken M, Ates G, Heymans A, Gmuender H, Bort R, Corvi R, Phrakonkham P, Li R, Mouchet N, Chesne C, van Delft J, Kleinjans J, Castell J, Herwig R, Rogiers V.

EXCLI J. 2014 May 28;13:623-37. eCollection 2014.

9.

Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian models.

Ribes J, Esteban L, Clèries R, Galceran J, Marcos-Gragera R, Gispert R, Ameijide A, Vilardell ML, Borras J, Puigdefabregas A, Buxó M, Freitas A, Izquierdo A, Borras JM.

Clin Transl Oncol. 2014 Aug;16(8):714-24. doi: 10.1007/s12094-013-1140-z. Epub 2013 Dec 12.

PMID:
24338506
10.

Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long-time echocardiography follow-up study.

Pardos-Gea J, Avegliano G, Evangelista A, Vilardell M, Ordi-Ros J.

Int J Rheum Dis. 2015 Jan;18(1):76-83. doi: 10.1111/1756-185X.12191. Epub 2013 Oct 17.

PMID:
24131635
11.

An integrative computational analysis provides evidence for FBN1-associated network deregulation in trisomy 21.

Vilardell M, Civit S, Herwig R.

Biol Open. 2013 Jun 20;2(8):771-8. doi: 10.1242/bio.20134408. eCollection 2013 Aug 15.

12.

DNA-methylome analysis of mouse intestinal adenoma identifies a tumour-specific signature that is partly conserved in human colon cancer.

Grimm C, Chavez L, Vilardell M, Farrall AL, Tierling S, Böhm JW, Grote P, Lienhard M, Dietrich J, Timmermann B, Walter J, Schweiger MR, Lehrach H, Herwig R, Herrmann BG, Morkel M.

PLoS Genet. 2013;9(2):e1003250. doi: 10.1371/journal.pgen.1003250. Epub 2013 Feb 7.

13.

Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models.

Doktorova TY, Yildirimman R, Vinken M, Vilardell M, Vanhaecke T, Gmuender H, Bort R, Brolen G, Holmgren G, Li R, Chesne C, van Delft J, Kleinjans J, Castell J, Bjorquist P, Herwig R, Rogiers V.

Carcinogenesis. 2013 Jun;34(6):1393-402. doi: 10.1093/carcin/bgt054. Epub 2013 Feb 7.

14.

Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations.

Labrador-Horrillo M, Martinez-Valle F, Gallardo E, Rojas-Garcia R, Ordi-Ros J, Vilardell M.

Lupus. 2012 May;21(6):611-5. doi: 10.1177/0961203312436856. Epub 2012 Feb 9.

PMID:
22323340
15.

Latent pulmonary inflammation in patients with systemic sclerosis.

Sánchez-Vidaurre S, Simeón CP, Cruz MJ, Fonollosa V, Vilardell M, Morell F, Muñoz X.

Arch Bronconeumol. 2012 Jan;48(1):8-13. doi: 10.1016/j.arbres.2011.06.010. Epub 2011 Nov 30. English, Spanish.

16.

Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial.

Cobo E, Cortés J, Ribera JM, Cardellach F, Selva-O'Callaghan A, Kostov B, García L, Cirugeda L, Altman DG, González JA, Sànchez JA, Miras F, Urrutia A, Fonollosa V, Rey-Joly C, Vilardell M.

BMJ. 2011 Nov 22;343:d6783. doi: 10.1136/bmj.d6783.

17.

Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity.

Yildirimman R, Brolén G, Vilardell M, Eriksson G, Synnergren J, Gmuender H, Kamburov A, Ingelman-Sundberg M, Castell J, Lahoz A, Kleinjans J, van Delft J, Björquist P, Herwig R.

Toxicol Sci. 2011 Dec;124(2):278-90. doi: 10.1093/toxsci/kfr225. Epub 2011 Aug 27.

18.

Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes.

Vilardell M, Rasche A, Thormann A, Maschke-Dutz E, Pérez-Jurado LA, Lehrach H, Herwig R.

BMC Genomics. 2011 May 11;12:229. doi: 10.1186/1471-2164-12-229.

19.

Efficacy of cyclophospamide in the treatment of interstitial lung disease associated with systemic sclerosis.

Espinosa G, Simeón CP, Plasín MÁ, Xaubet A, Muñoz X, Fonollosa V, Cervera R, Vilardell M.

Arch Bronconeumol. 2011 May;47(5):239-45. doi: 10.1016/j.arbres.2011.01.010. Epub 2011 Mar 31. English, Spanish.

20.

Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits.

Antonell A, Vilardell M, Pérez Jurado LA.

Hum Genet. 2010 Jul;128(1):27-37. doi: 10.1007/s00439-010-0817-4. Epub 2010 Apr 17.

PMID:
20401492
Items per page

Supplemental Content

Loading ...
Write to the Help Desk